Analysis of Postoperative Bleeding and Risk Factors in Transoral Surgery of the Oropharynx

Pollei, Taylor R.; Hinni, Michael L.; Moore, Eric J.; Hayden, Richard E.; Olsen, Kerry D.; Casler, John D.; Walter, Logan C.

doi:10.1001/jamaoto.2013.5097

Cited by 102 publications

(173 citation statements)

References 22 publications

Supporting

Mentioning

156

Contrasting

Unclassified

Order By: Relevance

“…Tumors originated from the tonsil (257), anterior tonsillar pillar (125), junction between anterior tonsillar pillar and tongue (51), posterior tonsillar pillar (31), lateral tongue base (20), glossotonsillar fold (19), or infratonsillar region (11). T staging, 17 N staging, 17 and the various anatomical subsites involved by the index cancer are documented in Table 1.…”

Section: Methodsmentioning

confidence: 99%

Postoperative Hemorrhage After Transoral Oropharyngectomy for Cancer of the Lateral Oropharynx

Laccourreye

Malinvaud

Garcia³

et al. 2014

Ann Otol Rhinol Laryngol

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Postoperative Hemorrhage After Transoral Oropharyngectomy for Cancer of the Lateral Oropharynx

Laccourreye

Malinvaud

Garcia³

et al. 2014

Ann Otol Rhinol Laryngol

View full text Add to dashboard Cite

show abstract

“…9 As these techniques have become more commonplace and surgeons have gained experience, improvements in outcomes have occurred, including decreased morbidity, shorter operative time, and reduced complications. 10,11 Oncologic outcomes following TORS compare favorably with those of other treatments. In a comparison of related studies of patients with HPV-positive lower T-stage disease, 2-year survival rates ranged from 91% to 96%, [12][13][14] with one review illustrating pooled 2-year overall survival rates of 82% to 94% following TORS.…”

mentioning

confidence: 99%

Transoral Robotic Surgery in Oropharyngeal Carcinoma

Helman¹,

Schwedhelm²,

Kadakia³

et al. 2015

Archives of Pathology &Amp; Laboratory Medicine

View full text Add to dashboard Cite

Context The incidence of oropharyngeal squamous cell carcinoma has increased during the past decade and is related primarily to the human papillomavirus. This change in etiology, from tobacco and alcohol to human papillomavirus, has resulted in improved survival for the disease. In the United States, open resection had largely been replaced by concurrent chemotherapy and/or radiotherapy by the early 2000s. The advent of transoral surgery has led to an increase in surgery as the primary treatment for both early- and advanced-stage oropharyngeal squamous cell carcinoma because it has potential advantages over open surgery and nonsurgical modalities. Objective To provide an overview of transoral robotic surgery for oropharyngeal squamous cell carcinoma and contrast it with other surgical and nonsurgical modalities. Data Sources Articles from 2000 to 2014 were accessioned on PubMed and reviewed for utility by the primary authors. Conclusions Transoral surgery has become more commonly used as a minimally invasive approach to treat oropharyngeal tumors. Other strategies, including radiation, chemotherapy with radiation, and open surgery, are still important treatment approaches. The treatment options for an individual patient rely on multiple factors, including the tumor location and size, features of the tumor, and patient comorbidities. The continued study of these techniques is important to match the patient with the most appropriate treatment.

show abstract

“…The importance of addressing level I in this setting has yet to be elucidated, but dissecting this level increases the risk of a fistula in synchronous procedures. It is generally agreed that at the time of the neck dissection, individual branches of the external carotid artery (lingual, facial and ascending pharyngeal) are identified and individually ligated to reduce the risk of postoperative haemorrhage after transoral surgery [31,32].…”

Section: Management Of the Neckmentioning

confidence: 99%

Transoral Robotic Surgery for Oropharyngeal Cancer

Paleri¹,

Fox²,

Winter³

2018

ORL

View full text Add to dashboard Cite

Transoral robotic surgery has shown significant promise in the management of oropharyngeal cancer since its description in 2007. The oncological efficacy of this procedure has been proven in several single-centre studies, multicentre collaborative publications and systematic reviews. The rapid take-up of transoral robotic surgery shows greater acceptance by professionals and is associated with a relatively short learning curve. This overview discusses the rationale and principles underlying the use of transoral robotic surgery in primary and recurrent oropharyngeal cancer and the emerging role for this technique in diagnosing the unknown primary site, and summarizes ongoing research in this field.

show abstract

Analysis of Postoperative Bleeding and Risk Factors in Transoral Surgery of the Oropharynx

Cited by 102 publications

References 22 publications

Postoperative Hemorrhage After Transoral Oropharyngectomy for Cancer of the Lateral Oropharynx

Postoperative Hemorrhage After Transoral Oropharyngectomy for Cancer of the Lateral Oropharynx

Transoral Robotic Surgery in Oropharyngeal Carcinoma

Transoral Robotic Surgery for Oropharyngeal Cancer

Contact Info

Product

Resources

About